Literature DB >> 10330450

Morphological and biochemical investigation of nitric oxide synthase and related enzymes in the rat and pig urothelium.

K Persson1, M Poljakovic, K Johansson, B Larsson.   

Abstract

We investigated the enzymes involved in the NADPH-diaphorase (d) reaction in the rat and pig bladder urothelium. The urothelial cell layer displayed intense and uniform NADPH-d activity. Preincubation with the flavoprotein inhibitor diphenyleneiodionium chloride (DPI) and the alkaline phosphatase inhibitor levamisole concentration-dependently decreased the urothelial NADPH-d activity. Immunoreactivities to neuronal (n), endothelial (e), or inducible (i) nitric oxide synthase (NOS) were not detected in rat or pig urothelial cells. In rats, the urothelium was uniformly immunoreactive for NADPH cytochrome P450 reductase, whereas the pig urothelium displayed inconsistent labeling. In lipopolysaccharide (LPS)-treated rats, the bladder urothelium showed positive iNOS immunoreactivity. The iNOS labeling was found predominantly in cells located in the basal layer of the urothelium. In the pig bladder mucosa, a Ca2+-dependent NOS activity was evident in cytosolic and particulate fractions that was quantitatively comparable to the NOS activity found in the smooth muscle. In ultrastructural studies of urothelial cells, NADPH-d reaction products were found predominantly on membranes of the nuclear envelope, endoplasmatic reticulum and mitochondria. In conclusion, NADPH-d staining of the urothelium cannot be taken as an indicator for the presence of constitutively expressed NOS. Activity of alkaline phosphatase and cytochrome P450 reductase may account for part of the NADPH-d reaction in urothelial cells. However, LPS treatment of rats caused expression of iNOS in urothelial cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330450     DOI: 10.1177/002215549904700603

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  7 in total

1.  Phosphodiesterase1 inhibitor "Vinpocetine" ameliorates the inflammation, apoptosis and oxidative stress induced by cyclophosphamide in urinary bladder: an experimental study.

Authors:  Rehab Sabri Abdelrahman; Eman Mohamad El Nashar; Mansour Abdullah Alghamdi; Khulood Mohammed Al-Khater; Reham Ismail Taha
Journal:  Int Urol Nephrol       Date:  2022-07-11       Impact factor: 2.266

2.  An ex vivo bladder model with detrusor smooth muscle removed to analyse biologically active mediators released from the suburothelium.

Authors:  Leonie Durnin; Benjamin Kwok; Priya Kukadia; Roisin McAvera; Robert D Corrigan; Sean M Ward; Ying Zhang; Qi Chen; Sang Don Koh; Kenton M Sanders; Violeta N Mutafova-Yambolieva
Journal:  J Physiol       Date:  2018-11-02       Impact factor: 5.182

3.  Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells.

Authors:  Lori A Birder; Michele L Nealen; Susanna Kiss; William C de Groat; Michael J Caterina; Edward Wang; Gerard Apodaca; Anthony J Kanai
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

Review 4.  The role of phosphodiesterases in bladder pathophysiology.

Authors:  Mohammad S Rahnama'i; Stefan Ückert; Ramona Hohnen; Gommert A van Koeveringe
Journal:  Nat Rev Urol       Date:  2013-05-14       Impact factor: 14.432

5.  Intimal hyperplasia in balloon dilated coronary arteries is reduced by local delivery of the NO donor, SIN-1 via a cGMP-dependent pathway.

Authors:  Jan Harnek; Evita Zoucas; Valéria Perez de Sá; Eva Ekblad; Anders Arner; Unne Stenram
Journal:  BMC Cardiovasc Disord       Date:  2011-06-11       Impact factor: 2.298

6.  Cascade bioassay evidence for the existence of urothelium-derived inhibitory factor in Guinea pig urinary bladder.

Authors:  Na N Guan; Anna Thor; Katarina Hallén; N Peter Wiklund; Lars E Gustafsson
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

Review 7.  Signalling molecules in the urothelium.

Authors:  Michael Winder; Gunnar Tobin; Daša Zupančič; Rok Romih
Journal:  Biomed Res Int       Date:  2014-08-10       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.